Galil Genetic Analysis Ltd. – G.G.A. Ltd.
G.G.A. Ltd. is the only company of its kind in Israel, and among the few laboratories in the world, which is authorized as a clinical laboratory by the Ministry of Health, an authorized OECD-GLP lab recognized and confirmed by the International Laboratory Accreditation Authority and ISO certified.
G.G.A. Ltd. is leading the revolution in genetic diagnostic testing in Israel. It is the largest private genetics laboratory, whose expertise includes Oncogenetics predisposition testing and pharmacogenetics testing for personalized medicine.
In the past, complex genetic testing was carried out abroad resulting in prolonged diagnosis and treatment. G.G.A. Ltd. equipped with state of the art technologies, specializes in high performance testing using innovative DNA chips that will detect more data, with greater efficiencyand accuracy, at a reduced turnaround time and a lower cost.
G.G.A. Ltd. expertise includes:
• Molecular Genetics diagnostic testing.
• "In-house" research and development.
• Innovative development and application of array chips.
• Molecular Genetics research outsourcing, servicing external organizations.
• Provides DNA testing and offers expert, professional opinion for the legal system.
• Development and implementation of genetic laboratories servicing underdeveloped countries.
G.G.A. Ltd. laboratories
G.G.A. Ltd. laboratories and spacious offices are distributed over an area of 800 square meters. The facilities are comprised of the latest scientific equipment, some of which are automated by sophisticated robots for molecular testing, DNA/RNA array systems, DNA sequencing systems and RT-PCR.
G.G.A. Ltd. staff
All of the professional staff have M.Sc., PhD. or M.D. degrees, with years of experience in the field of genetics and molecular biology. The G.G.A. Ltd. laboratory team is individually certified by the Ministry of Health.
GGA believes that by means of the genetic testing it offers:
All patients will have a confirmed diagnosis will receive the most appropriate medical and pharamceutical treatment.
Each person will be able to be aware of the potential medical risks according to his genetic background and to that of his family members, and thus will be able to reduce the risk for other family members
In each individual medical record, the predicted reactions to drugs will be listed, so that when necessary, he will be treated accordingly.
Pharmaceutical treatment will no longer be provided by method of trial and error.